SALERNO, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 5.164
EU - Europa 2.989
AS - Asia 1.013
AF - Africa 117
OC - Oceania 18
SA - Sud America 10
Totale 9.311
Nazione #
US - Stati Uniti d'America 5.020
IT - Italia 1.279
SE - Svezia 550
CN - Cina 451
DE - Germania 344
BG - Bulgaria 228
GB - Regno Unito 148
SG - Singapore 147
CA - Canada 141
TR - Turchia 138
AT - Austria 122
VN - Vietnam 106
UA - Ucraina 92
FI - Finlandia 79
IN - India 59
JP - Giappone 55
CI - Costa d'Avorio 54
HK - Hong Kong 37
FR - Francia 34
NG - Nigeria 30
CH - Svizzera 29
SN - Senegal 22
BE - Belgio 21
RU - Federazione Russa 21
AU - Australia 16
CZ - Repubblica Ceca 14
EG - Egitto 10
NL - Olanda 9
GR - Grecia 6
BR - Brasile 4
EC - Ecuador 4
IR - Iran 4
ID - Indonesia 3
MX - Messico 3
PL - Polonia 3
ES - Italia 2
IE - Irlanda 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KZ - Kazakistan 1
MC - Monaco 1
MD - Moldavia 1
MY - Malesia 1
SA - Arabia Saudita 1
Totale 9.311
Città #
Woodbridge 746
Ann Arbor 631
Houston 595
Serra 508
Chandler 440
Fairfield 404
Ashburn 291
Milan 272
Sofia 228
Seattle 177
Wilmington 170
Beijing 168
New York 156
Jacksonville 138
Izmir 136
Ottawa 130
Cambridge 129
Princeton 111
Vienna 106
Lawrence 97
Nanjing 79
London 78
Medford 78
Singapore 59
Des Moines 55
Abidjan 54
Dong Ket 52
Frankfurt am Main 52
Dearborn 46
Rho 45
Hong Kong 35
Rome 34
Boulder 31
Lagos 30
Bremen 29
Bern 26
Düsseldorf 25
Jüchen 25
Pisa 25
San Jose 25
Los Angeles 23
Nanchang 23
Pune 23
Redwood City 23
Dakar 22
Kunming 22
Brussels 21
San Diego 19
Ogden 18
Changsha 17
Hebei 17
Nürnberg 17
Florence 15
Washington 15
Shenyang 14
Aversa 13
Hefei 13
Boardman 12
Jiaxing 11
Livorno 11
Norwalk 11
Pessac 11
Vercelli 11
San Francisco 9
Tianjin 9
Falls Church 8
Hangzhou 8
Jinan 8
Sydney 8
Toronto 8
Auburn Hills 7
Brno 7
Lancaster 7
Vicopisano 7
Council Bluffs 6
Kyoto 6
Orange 6
Tappahannock 6
Cascina 5
Caserta 5
Cecina 5
Citta 5
Garbagnate Milanese 5
Guangzhou 5
Lucca 5
Marseille 5
Melbourne 5
Phoenix 5
Prague 5
Talence 5
Cairo 4
Castelnuovo di Garfagnana 4
Dallas 4
Indiana 4
Amsterdam 3
Chicago 3
Chiyoda-ku 3
Gaeta 3
Helsinki 3
Hyderabad 3
Totale 7.102
Nome #
1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions 316
Benzofuroxane Derivatives as Multi Effective Agents for the Treatment of Cardiovascular Diabetic Complications. Synthesis, Functional Evaluation, and Molecular Modeling Studies 198
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 179
Deepening the Topology of the Translocator Protein Binding Site by Novel N,N-Dialkyl-2-arylindol-3-ylglyoxylamides 165
Identification of Anxiolytic/Nonsedative Agents among Indol-3-ylglyoxylamides Acting as Functionally Selective Agonists at the γ-Aminobutyric Acid-A (GABAA) α2 Benzodiazepine Receptor 160
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities 160
Refinement of Structure-activity Relationships of the Triazinobenzimidazole A1AR Antagonists 143
5-Amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a Versatile Scaffold to Obtain Potent and Selective A3 Adenosine Receptor Antagonists 139
FACILE SYNTHESIS OF 3-SUBSTITUTED[1,2,4]TRIAZINO[3,4-F]PURINE-4,6,8-TRIONE DERIVATIVES 138
Benzo[d]isothiazoles and Matrix Metalloproteinases. Searching for Novel and Selective Inhibitors of MMP9 136
Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs 136
Synthesis of Purinobenzodiazepine and Purinobenzotriazocine derivatives, two new heterocyclic ring systems. 135
Benzothiopyranoindole-Based Antiproliferative Agents: Synthesis, Cytotoxicity, Nucleic Acids Interaction, and Topoisomerases Inhibition Properties. 133
Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII 133
“Synthesis and antiproliferative evaluation of new substituted Benzothiopyrano[4,3-c] condensed ring systems” 132
Medicinal chemistry of indolylglyoxylamide TSPO high affinity ligands with anxiolytic-like effects 129
Novel N(2)-Substituted Pyrazolo[3,4-d]pyrimidine Adenosine A(3) Receptor Antagonists: Inhibition of A(3)-Mediated Human Glioblastoma Cell Proliferation (dagger) 126
Synthesis of Pyrimido[1,2-a]benzimidazol-4(10H)-one Derivatives and Evaluation of their Interactions with DNA 124
Synthesis of novel pyrido[3',2':5,6]thiopyrano[3,2-b]indol-5(6H)-ones and 6H-pyrido[3',2':5,6]thiopyrano[4,3-b]quinolines,two new heterocyclic systems. 123
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of non-camptothecin Topoisomerase I (Top1) inhibitors 123
An update into the medicinal chemistry of translocator protein (TSPO) ligands 123
Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies. 121
Medicinal chemistry of indolylglyoxylamide GABAA/BzR high affinity ligands: identification of novel anxiolytic/non sedative agents 119
Synthesis of novel 1,4-dihydropyrido[3’,2’:5,6]thiopyrano[4,3-c]-pyrazoles and 5H-pyrido[3’,2’:5,6]thiopyrano[4,3-d]pyrimidines as potential antiproliferative agents 118
Synthesis of New Heterocyclic Ring Systems via [1,3,5]Triazino[1,2-a]benzimidazole Derivatives 118
Acetic acid aldose reductase inhibitors bearing a five-membered heterocyclic core with potent topical activity in a visual impairment rat model 118
Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity 115
Synthesis, DNA binding and in vitro antiproliferative activity of purinoquinazoline, pyridopyrimidopurine and pyridopyrimidobenzimidazole derivatives as potential antitumor agents 114
Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2 114
Synthesis and biological activity of 1,4-dihydrobenzothiopyrano[4,3-c]pyrazole derivatives, novel pro-apoptotic mitochondrial targeted agents 113
Mitochondrial permeability transition induced by novel pyridothiopyranopyrimidine derivatives: Potential new antimitochondrial antitumour agents. 112
Pyrazolo[3,4,-d]pyrimidine-4-one Derivatives as Novel and Potent Inhibitors of Adenosine Deaminase 110
Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation. 109
Translocator protein (tspo) ligand residence time: a new parameter to predict neurosteroidogenic efficacy for n,n-dialkyl-2-arylindol-3-ylglyoxylamides (PIGAs) 109
Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A1 and A2B adenosine receptor subtypes 109
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A(2B) adenosine receptor antagonists 108
Microwave-assisted Suzuki Coupling in Aqueous Media: a Useful Tool for the Synthesis of 3-Arylindazole Derivatives 106
Novel Irreversible Fluorescent Probes Targeting the 18 kDa Translocator Protein: Synthesis and Biological Characterization 105
Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases 104
Novel Aldose Reductase Acetic acid Inhibitors Bearing a Five Membered heterocyclic core 103
1-(PHENYLSULPHONAMIDO)-PYRAZOLE DERIVATIVES AS CARBONIC ANHYDRASE INHIBITORS. 101
Derivati spiroidantoinici del Tiopirano[2,3-b]piridin-4(4H)-one quali potenti inibitori dell’aldoso reduttasi 100
Geometrically Constrained Derivatives of Indolylglyoxylamides as Ligands Binding the GABAA/BzR Complex. 100
Novel positive allosteric modulators of A2B adenosine receptor acting as bone mineralisation promoters 100
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A(2B) Adenosine Receptor Antagonists. 98
4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors 96
Novel Antitumoral Pyrazolopyrimidines Based on Inhibition of Protein Tyrosine Kinase 95
Spirohydantoin Derivatives of Thiopyrano[2,3-b]pyridin-4(4H)-one as Potent in Vitro and in Vivo Aldose Reductase Inhibitors 95
Synthesis and biological evaluation of Modified 2-Phenylindol-3-ylglyoxylamides as good candidates for the development of radioligands for the visualization of peripheral benzodiazepine receptor 94
Discovery of Pyrido[3′,2′:5,6]thiopyrano[4,3- d]pyrimidine-Based Antiproliferative Multikinase Inhibitors 93
Design, Synthesis, and Biological Evaluation of 3-Arylindazole Acetic Acid Derivatives as Aldose Reductase Inhibitors 90
"Synthesis of pyridothiopyranoindole and of pyridothiopyranoquinoline derivatives as novel tetracyclic ring system" 90
New oxazole and 1,2,4-oxadiazole derivatives as selective ligands at the Translocator Protein (TSPO) 90
Pyridopyrimidinone Derivatives as Novel Therapeutic Agents for the Topic Treatment of Vessel Walls Subjected to Percutaneous Intervention 89
Exploiting the pyrazolo[3,4-d]pyrimidinone ring system as a useful template for the obtainment of potent adenosine deaminase inhibitors 87
"Synthesis, DNA binding and in vitro antiproliferative activity of quinazobenzimidazole derivatives as potential antitumor agents". 87
Anxiolytic-like Effects of N,N-Dialkyl-2-phenylindol-3-ylglyoxylamides by Modulation of Translocator Protein Promoting Neurosteroid Biosynthesis 86
Synthesis and antiproliferative evaluation of new aryl substituted Pyrido[3’,2’:5,6]thiopyrano[4,3-c]pyrazoles 85
SYNTHESIS OF NOVEL 5H,11H-PYRIDO[2',3':2,3]THIOPIRANO[4,3-B]-INDOLES BY FISCHER-INDOLE CYCLIZATION. 84
Design, synthesis, and biological evaluation of novel fluorescent probes targeting the Translocator Protein (18 kDa) (TSPO) 84
Synthesis, in vitro antiproliferative activity and DNA-interaction of benzimidazoquinazoline derivatives as potential anti-tumor agents 83
Novel Pyrazolopyrimidine Derivatives as Therapeutic Agents for the Treatment of Medullary Thyroid Carcinoma 78
Tricyclic Sulfonamides Incorporating Benzothiopyrano[4,3-c]pyrazole and Pyridothiopyrano[4,3-c]pyrazole Effectively Inhibit a- and ß-Carbonic Anhydrase: X-ray Crystallography and Solution Investigations on 15 Isoforms 78
High Affinity Central Benzodiazepine Receptor Ligands: Synthesis and Biological Evaluation of a Series of Phenyltriazolobenzotriazindione Derivatives (PTBTs) 77
Carbonic anhydrase activation profile of indole-based derivatives 77
NOVEL KINASE INHIBITORS IN THYROID CANCER TREATMENT: SYNTHESIS AND BIOLOGICAL EVALUATION 76
Synthesis and Antiproliferative Activity of New Aminoalkyl Substituted Benzothiopyranoindoles 76
New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors 76
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of noncamptothecin Topoisomerase I (top1) inhibitors 74
Targeting the Translocator protein (TSPO) with 2-phenylindol-3-ylglyoxylamide derivatives 73
2-(phenylsulphonamido)-pyrazole derivatives as carbonic anhydrase inhibitors 73
Benzoxadiazole Derivatives: Atypical Inhibitors of Aldose Reductase 72
"Sintesi e attività antiproliferativa di sistemi Pirido[3’,2’:5,6]tiopirano[4,3-c]pirazolici 2-aril sostituiti" 71
"Synthesis of purinobenzodiazepine and purinobenzotriazocine derivatives, two new heterocyclic ring system" 70
Synthesis and biological evaluation on human glioblastoma cells of novel pyrazolo[3,4-d]pyrimidine adenosine A(3) receptor antagonists. 70
Substituted 2-Arylindolglyoxylamides as Potent Translocator Protein (18 kDa) TSPO ligands: Synthesis and Biological Evaluation 69
Tetrahydroquinazole-based secondary sulphonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IV, and IX, and computational studies 69
Refinement of the translocator protein pharmacophore/receptor model via structure-activity relationships of novel N,N-dialkylindolylglyoxylamides 67
Inhibition studies on carbonic anhydrase isoforms I, II, IV and IX with N-arylsubstituted secondary sulfonamides featuring a bicyclic tetrahydroindazole scaffold 66
Synthesis and in vitro Antiproliferative Activity of New Substituted Benzo[3',2':5,6]thiopyrano[4,3-d]pyrimidines 64
Novel 3-Aryl-1,2,4triazino4,3-abenzimidazol-4(10H)-ones (ATBI) as selective A2A adenosine receptor antagonists 63
Multiple Topoisomerase I (TopoI), Topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs 63
"Facile sintesi di nuove molecole polieterocicliche a partire dal 2-guanidinobenzimidazolo" 61
3-Aryl-1,2,4-triazino-4,3-abenzimidazol-4(10H)-one: a novel template for the design of highly selective A2B adenosine receptor antagonists 57
Synthesis and biological evaluation on human glioblastoma cells of novel pyrazolo3,4-Dpyrimidine adenosine A3 receptor antagonists 51
Carbonic Anhydrase Activators for Neurodegeneration: An Overview 51
New antiproliferative agents derived from tricyclic 3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazine scaffold: synthesis and pharmacological effects 49
Lead optimization of a novel molecular scaffold in search for novel MMP-13 inhibitors 49
New suitable scaffolds for the development of non camptothecin topoisomerase I (Top1) inhibitors 47
Targeting the KRAS oncogene: Synthesis, physicochemical and biological evaluation of novel G-Quadruplex DNA binders 44
Refinement of the Mitochondrial Translocator Protein Pharmacophore/Receptor Model via Structure-activity Relationships of Novel N,N-Dialkylindolylglyoxylamides. 42
Sintesi, attività biologica e studio del meccanismo d’azione di nuovi derivati Pirido[3’,2’:5,6]tiopirano[4,3-d]pirimidinici 40
Refinement of the Mitochondrial Translocator Protein Pharmacophore/Receptor Model via Structure-Activity Relationships of Novel N,N-Dialkylindolylglyoxylamides 40
Targeting TSPO Reduces Inflammation and Apoptosis in an In Vitro Photoreceptor-Like Model of Retinal Degeneration 38
Design and synthesis of a novel irreversible fluorescent ligand for the visualization of Translocator Protein (18kDa) 37
Synthesis, antiproliferative activity and VEGFR-2 inhibition of new anilino substituted thiopyrano-fused pyrimidines 34
A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells 29
Drug repurposing meets DNA independent pathways: targeting alternative substrates for anticancer therapy 29
Cancer Immunotherapy: An Overview on Small Molecules as Inhibitors of the Immune Checkpoint PD-1/PD-L1 (2015-2021) 27
Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents 26
Totale 9.456
Categoria #
all - tutte 24.462
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.462


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.409 0 120 385 85 116 139 154 83 109 82 123 13
2020/2021756 163 23 50 36 75 31 34 63 60 43 49 129
2021/20221.155 40 95 53 69 178 150 37 51 41 37 57 347
2022/20231.631 198 281 115 147 202 202 18 114 263 6 64 21
2023/20241.347 144 134 150 92 161 275 102 49 12 22 88 118
2024/202532 30 2 0 0 0 0 0 0 0 0 0 0
Totale 9.524